Orion Oyj B
FIEUROrion Oyj B (LSE:0M2O) — Drug Manufacturers - General. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 3. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- orionpharma.com
- Sektor
- Healthcare · Drug Manufacturers - General
- Hauptsitz
- Espo, Finland
- CEO
- Liisa Hurme
- Mitarbeiter
- 4 000
- Börsennotiert Seit
- 07.11.2007 (LSE:0M2O)
- Ausstehende Aktien
- 108.99 Mio.
- Streubesitz
- 123.49 Mio.
- Marktkapitalisierung
- 11.42 Mrd. EUR
- Insider
- 2.63%
- Institutionelle Anleger
- 45.48%
- Ausschüttungsquote
- 41.3%
- FCF
- 380 Mio. EUR
- Ausschüttung / FCF
- 64%
- Schulden
- 133 Mio. EUR0.3 J. FCF
- Dividendenserie
- 21 J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 30.06.2026 (letzter Bericht des Unternehmens).
Beschreibung
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.
Dividenden
Orion Oyj B (ORINF) zahlt zweimal jährlich Dividenden. Pro Jahr (12 Monate bis einschließlich der zuletzt angekündigten Zahlung): 1.8 EUR pro Aktie (Zahlungen: 1). Der nächste Ex-Dividenden-Tag ist der 20.10.2026: 0.9 EUR pro Aktie, Zahlung am 27.10.2026. Ununterbrochene Dividendengeschichte: 21 Jahre.
| Ex-tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-20 angekündigt | 2026-10-27 | 0.9000 EUR | 1.1/2.2 % | halbjährlich | US:ORINF |
| 2026-03-25 | 2026-04-02 | 0.9000 EUR | 1.3/2.6 % | halbjährlich | HE:ORNBV |
| 2025-10-15 | 2025-10-23 | 0.8200 EUR | 1.2/2.4 % | halbjährlich | HE:ORNBV |
| 2025-04-04 | 2025-04-14 | 0.8200 EUR | 1.5/2.9 % | halbjährlich | HE:ORNBV |
| 2024-10-15 | 2024-10-23 | 0.8100 EUR | 1.7/3.4 % | halbjährlich | HE:ORNBV |
| 2024-03-21 | 2024-04-03 | 0.8100 EUR | 2.3/2.3 % | jährlich | HE:ORNBV |
| 2023-03-23 | — | 1.6000 EUR | 3.7/3.7 % | jährlich | HE:ORNBV |
| 2022-03-24 | — | 1.5000 EUR | 3.5/3.5 % | jährlich | HE:ORNBV |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| BlackRock, Inc. | ≈6.43% | 7.07 Mio. | 2025-04-24 |
| VANGUARD STAR FUNDS-Vang… | 1.42% | 1.56 Mio. | 2026-07-31 |
| VANGUARD TAX-MANAGED FUN… | 0.95% | 1.04 Mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.75% | 825 344 | 2026-08-31 |
| DFA INVESTMENT TRUST CO-… | 0.55% | 600 779 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.45% | 497 917 | 2026-07-31 |
| Fidelity Concord Street… | 0.39% | 426 245 | 2026-07-31 |
| iShares Trust-iShares MS… | 0.35% | 379 664 | 2026-08-31 |
| SPDR-EUROPE-SSgA SPDR ET… | 0.34% | 374 245 | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.23% | 254 097 | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.23% | 253 858 | 2026-07-31 |
| Pacer Advisors, Inc. | 0% | 485 | 2026-06-30 |
